In the mouse, the Nfe2l3 gene has been shown to be significantly upregulated in the colonic mucosa of mice following AOM/DSS treatment [24], yet its function in inflammation-induced colon cancer has not been investigated. This evidence concerns the gene NFE2L3 and malignant colon neoplasm.